Children's Hospital Colorado
Amy Keating, MD
Cancer and Blood Disorders

Amy Keating, MD

Associate Professor of Pediatrics

Specialties:
Hematology/Oncology - Pediatric
Conditions:
Aplastic Anemia, Pediatric Cancer, Leukemia (Childhood), Blood and Marrow Transplant, Blood Disorders
See more
specialties:

Hematology/Oncology - Pediatric

conditions:

Aplastic Anemia, Pediatric Cancer, Leukemia (Childhood), Blood and Marrow Transplant, Blood Disorders, Immunodeficiency

Meet Amy Keating, MD

My goal is to work with our outstanding team to provide the very best care for children needing a bone marrow transplant, including new, cutting edge research treatments when appropriate. I believe that children are treated along with their family and caregivers, and that the entire medical team must support that goal.

Get to know her background

I am interested in all areas of pediatric bone marrow transplant, with a particular emphasis on improving the outcomes of children with leukemia and other cancers.

Undergraduate 1995

University of Illinois–Urbana-Champaign (IL)

Medical School 1999

Northwestern University The Feinberg School of Medicine

Residency 2003

Loyola University Medical Center, Pediatrics

Fellowship 2007

University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology

Outstanding Service and Education 2011

This award is given as special recognition by the residents and fellows of the hospital to faculty that are felt to go above and beyond in medical education.
Children's Hospital Colorado Housestaff Association

Young Investigator Award 2011

Award is given in recognition of the most outstanding report of original research presented at the annual national meeting. Research was presented at a special plenary session.
American Society of Pediatric Hematology and Oncology

For Patients:
My research interests are focused on the development of new therapies (clinical trials) for children needing a bone marrow transplant. Our group offers a large variety of research opportunities for our patients, but I am particularly interested in new ways to treat relapsed leukemia and using cell therapies for treatment and prevention of complications.
For Referring Providers:
My research career began with basic science investigations into the role of the TAM family of receptor tyrosine kinases in malignancy and inflammation. More recently I have been focused on the development of clinical research trials for bone marrow transplant patients, with particular interests in novel approaches for the patient with leukemia and the development of cellular therapeutics for a multitude of uses.

Associate Professor of Pediatrics


PRODWEBSERVER2